
Sign up to save your podcasts
Or
Send us a Text Message (please include your email so we can respond!)
Episode 24! Three trials about COVID were published with ESICM which we talk about all three here. COVID has been decreasing in prevalence in our ICU at least so we anchor our discussion around what we can learn from these trials about ARDS in general or what we can carry forward to future pandemics compared to our typical "Are we using this in our practice".
Simvastatin: https://pubmed.ncbi.nlm.nih.gov/37888913/
Vitamin C: https://pubmed.ncbi.nlm.nih.gov/37877585/
Convalescent Plasma: https://pubmed.ncbi.nlm.nih.gov/37889107/
If you enjoy the show be sure to like and subscribe, leave that 5 star review! Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at [email protected] with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!
4.9
6262 ratings
Send us a Text Message (please include your email so we can respond!)
Episode 24! Three trials about COVID were published with ESICM which we talk about all three here. COVID has been decreasing in prevalence in our ICU at least so we anchor our discussion around what we can learn from these trials about ARDS in general or what we can carry forward to future pandemics compared to our typical "Are we using this in our practice".
Simvastatin: https://pubmed.ncbi.nlm.nih.gov/37888913/
Vitamin C: https://pubmed.ncbi.nlm.nih.gov/37877585/
Convalescent Plasma: https://pubmed.ncbi.nlm.nih.gov/37889107/
If you enjoy the show be sure to like and subscribe, leave that 5 star review! Be sure to follow us on the social @icucast for the associated figures, comments, and other content not available in the audio format! Email us at [email protected] with any questions or suggestions! Thank you Mike Gannon for the intro and exit music!
1,868 Listeners
534 Listeners
244 Listeners
486 Listeners
3,332 Listeners
253 Listeners
1,094 Listeners
181 Listeners
699 Listeners
242 Listeners
408 Listeners
248 Listeners
361 Listeners
54 Listeners
215 Listeners